Ifabotuzumab (Synonyms: KB004) |
Catalog No.GC69258 |
Ifabotuzumab (KB004) is an IgG1κ antibody that targets EphA3 (KD=610 pM). Ifabotuzumab can induce apoptosis in tumor cells and activate antibody-dependent cell-mediated cytotoxicity (ADCC), which destroys the tumor vascular system. Ifabotuzumab can reduce CCR10+ cells in idiopathic pulmonary fibrosis (IPF) patients, improving lung fibrosis.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2147698-66-4
Sample solution is provided at 25 µL, 10mM.
Review for Ifabotuzumab
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Ifabotuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *